Overview of the microbiota in the gut-liver axis in viral B and C hepatitis

doi:10.3748/wjg.v27.i43.7446

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 43

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6713)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

422

WORD

199

HTML

3266

Figures (1-2)

392

Tables (1-2)

541

Sum=4820

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

352

Download

497

Sum=849

Publishing Process of This Article

Item

Count

Browse

401

Download

643

Sum=1044

Nov 21, 2021 (publication date) through Nov 16, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Nov 21, 2021; 27(43): 7446-7461
Published online Nov 21, 2021. doi: 10.3748/wjg.v27.i43.7446

Table 2 Microbial changes as a result of several treatments in viral B and C hepatitis

Drug	Type of study	Changes in gut microbiota	Ref.
Entecavir	Experimental (mice)	↑ Lachnospiraceae, Akkermansia, Alistipes, Escherichia, Shigella, Oscillibacter, Bilophila	Li et al[127]
Entecavir	Clinical	↑ Clostridium sensu stricto 1, Erysipelotrichaceae UCG-007, Intestinibacter; ↓ Streptococcus, Atopobium, and Murdochiella	Lu et al[128]
Direct antiviral agents in patients with HCV infection	Clinical	↑ Phylum Firmicutes, genera Lachnospira	Pérez-Matute et al[129]
Direct antiviral agents in patients with HCV-related liver cirrhosis	Clinical	↓ Enterobacteriaceae, Staphylococcus and Veillonellaceae	Ponziani et al[130]

HCV: Hepatitis C virus.

Citation: Neag MA, Mitre AO, Catinean A, Buzoianu AD. Overview of the microbiota in the gut-liver axis in viral B and C hepatitis. World J Gastroenterol 2021; 27(43): 7446-7461
URL: https://www.wjgnet.com/1007-9327/full/v27/i43/7446.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i43.7446